|
|
 |
|
Viewing report
|
|
|
|
Anti-Infective Drugs Markets
TriMark Publications, Oct 2010, Pages: 243
Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide, killing mostly children and young adults, according to the World Health Organization (WHO). Moreover, threatening pandemics such as swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world.
This report analyzes the anti-infective drugs market and highlights the existing and developing anti-infectives used to ameliorate infectious diseases' afflictions on humankind. Anti-infective drugs include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Particular attention is paid to the clinical market segment and the pharmaceutical/biotechnology companies involved in anti-infective drugs with specific emphasis on each company's sales focus, product portfolio and R&D pipeline. To date, the most successful anti-infective drugs target the human immunodeficiency virus (HIV, the virus that causes AIDS), the herpes virus (HSV-1 and HSV-2), bacterial infections and hepatitis C (HCV). A number of exciting novel anti-viral and antibiotic compounds are currently revolutionizing anti-infective drugs markets, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapies, respectively. Significant resources are also being dedicated toward hepatitis A (HAV), hepatitis B (HBV) and Staph infections, including MRSA.
What's more, this study will examine the existing and developing anti-infective drugs targeted at infectious diseases that continue to devastate developing countries, including: cholera, dengue fever, meningitis, rotavirus, typhoid and yellow fever.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
Cell Therapy Markets
Indian Pharmaceutical Industry
Medical Nanotechnology Markets
Cell-Based Assays for Drug Discovery
Companion Biomarkers in Drug Development
Pharmacogenomics for Clinical Use and in Drug Development
Therapeutic Monoclonal Antibodies Markets
Pharmaceuticals Report Bundle
Customers who bought this item also bought
Anti-Infectives - Global Strategic Business Report
Hospital Acquired Bacterial Infections Market to 2016 - Increasing Antibiotic Resistance and Increasing Population of Critically Ill Patients To Drive Growth
Antibiotics and Drug Resistance 2008
The Global Market for AntiMicrobials and Antifungals; Challenging Resistance to 2015
The Antivirals Pipeline: Competitive Review
Antibiotic Resistance 2012: The Antibiotic Development Pipeline and Strategies to Combat Antibiotic Resistance
The Global Market for Fixed-Dose Combination Drugs for Leading Diseases
Antibacterial Drugs - Global Strategic Business Report
The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain Market Growth Despite Major Patent Expiries
|
|
|
|
